therapeutic action: urease inhibition

First Chemical Investigation of Korean Wild Mushroom, Amanita hemibapha subsp. javanica and the Identification of Anti-Helicobacter pylori Compounds

mycolabadmin

Researchers studied a Korean edible mushroom called Amanita hemibapha subsp. javanica and found it contains compounds that can kill the bacteria Helicobacter pylori, which causes stomach ulcers and gastric cancer. One compound in particular showed strong antibacterial activity, performing even better than some known antibiotics. These findings suggest this mushroom could be a natural source for developing new medicines to treat H. pylori infections and fight antibiotic-resistant strains.

Read More »

Editorial: Innovation in tackling the global challenge of eradicating antibiotic-resistant microorganisms

mycolabadmin

Antibiotic resistance is a serious global health problem causing millions of deaths annually. Scientists are developing new approaches to fight resistant bacteria, including using bacteriophages (viruses that attack bacteria), improving detection methods, and testing plant-based compounds. This editorial discusses 15 research papers showing various innovative strategies, emphasizing that we need multiple tools working together rather than relying on any single solution to solve this complex problem.

Read More »

Investigation of the In Vitro Antioxidant, Anticholinesterase, Antiurease, Antityrosinase, and Cytotoxic Properties of a Novel Compound: 4-Methoxy-2-(4-Methoxyphenyl)Benzo[d][1,3,2]Dioxaborole

mycolabadmin

Scientists created a new chemical compound containing boron that showed promise as a potential medicine. The compound was effective at neutralizing harmful molecules in cells and inhibiting enzymes related to Alzheimer’s disease. Importantly, it did not damage healthy cells or kill cancer cells, suggesting it could be safe for future medical applications in treating various diseases.

Read More »
Scroll to Top